Introduction
Cancer is one of the major health problems of this century. 1 Approximately 12.7 million cancer cases were reported around the world in 2008, and this number is estimated to increase to 21 million by 2030. 2 In general, cancers are slightly more prevalent in men (6.6 million cases) compared with women (∼6.0 million). 3 Breast cancer is one of the most common cancers diagnosed in women, which causes more deaths per year than any other types of cancer. 4 The number of cases diagnosed with breast cancer in Asia has increased steadily over the last several years. 5 In 2006, patients with breast cancer represented 16 .5% of all cancer cases reported in Malaysia. 6 Breast cancer is not only the second leading cause of death in Malaysia but also a significant threat to the composition of the society and the national income. In the year 2009, $86.6 billion Chemotherapy, surgery and radiotherapy are considered as the most common and efficient methods of cancer treatment, although these methods cause severe side effects. 8, 9 Gradual resistance of cancer cells against the treatment is considered as one of the biggest problems in cancer therapy, Hence, achieving a new approach to cancer therapy is an important aspect in pharmacological studies to improve the results of cancer treatment. In recent years, plants have played an important role in controlling cancer symptoms and treatments. 10, 11 Iran is one of the Asian countries characterized by a diversity of both climate and geographical landscapes. The wide surface area of the country produces 8,000 species of wild plants, and ∼700 of these species are classified as medicinal plants. 12 Kelussia odoratissima Mozaff. is one of the important plants that belongs to the Umbelliferae family and possesses potential medicinal values. It is solely found in Iran, mainly around the Zagros Mountains at 2,500 m above sea level. This plant is locally called kelus or Karafs-e-Bakhtiari, and the aerial part of this plant has a high nutritional value due to which natural healers use the plant for its antioxidant, sedative, antiulcerative and anti-inflammatory properties and in the management of cardiovascular disorders. [13] [14] [15] In 2015, Behbahani 16 showed that the methanol extracts of flower and leaf and seed extracts of K. odoratissima have a potent cytotoxic effect on MCF7 cells. Approximately 27 compounds have been identified from the essential oil of K. odoratissima. 17, 18 However, due to the few scientific studies on the different parts of this plant, this study was designed to ascertain the potential apoptotic nature of K. odoratissima methanol extracts (KMEs) on breast cancer adenoma cells using appropriate mechanisms and correlate the potential in vitro results with in vivo study models.
general procedures
Silica gel 60 (40-63 μm; Merck, Darmstadt, Germany) was used to run column chromatography (CC). TLC was completed on glass and aluminum plates, pre-coated with silica gel 60 F 254 (Merck). Preparative high-performance liquid chromatography (HPLC) was performed with a Waters 2707 instrument (Waters, Milford, MA, USA) with a C-18 Luna column (250 mm×21.2 mm, 5 μm; CA, USA) and PDA 2998 detector (Waters).
1 H and 13 C 1D NMR and 2D NMR spectra were determined in JEOL JNM-FX500, and the UV spectra were recorded on a Shimadzu UV-160A spectrophotometer using ethanol as the solvent. The MS data were obtained with an Agilent 6530. The IR spectra were measured by Fourier transform IR (FT-IR) spectroscopy using a Perkin-Elmer RX 1 spectrometer for the 4,000-400 cm −1 frequency range.
Extraction, purification and isolation methods
Approximately 2.5 kg of K. odoratissima powder was extracted at room temperature (Ca. 24°C-27°C) using hexane, chloroform and methanol solvents. The extracts were prepared by soaking 100 g of the coarse powdered plant in 1,000 mL of 95% solvent at room temperature for ∼3-4 days. Then, the mixture was filtered, followed by evaporation under low pressure at 45°C using a Buchi-type rotary evaporator to get the dried crude extract. The final yield was calculated as "weight of the crude extract/weight of fresh plant" for every 100 mg plant material. Methanol crude extract of KME was concentrated and eluted through a silica gel column (CH 2 Cl 2 /MeOH, 100:0 → 50:50), by which four subfractions were obtained. Fraction three was further purified by a preparative HPLC (50%-100% MeOH/H 2 O with detection at 252 nm, and a flow rate of 7 mL/min, C18 Column) to yield 8-hydroxy-ar-turmerone ( Figure 1 
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KMe activates intrinsic pathway of apoptosis in breast cancer cells 48 and 72 h, respectively, and then treated with MTT for 3 h and DMSO was added. The colorimetric changes were measured at 570 nm absorbance, and the results were calculated as the percentage of the growth inhibition power.
animals
A total of 30 female Sprague Dawley ® strain rats (180-250 g) were purchased from the animal house facility, Faculty of Medicine, University of Malaya, Malaysia. All the animals were kept in a temperature-controlled room (∼24°C) and were supplied with water ad libitum and standard rat pellets. The animal experiment was approved by the ethics committee of the University of Malaya (FAR/26/07/2013HK).
acute toxicity
Rats weighing an average of 180 g and aged 6-8-week were obtained from the animal house facility, Faculty of Medicine, University of Malaya. The animals were treated with care according to the Guidelines for the Care of Laboratory Animals. A total number of 18 female rats were divided into three different groups placed in three different cages.
The first group was fed with Tween 20 10% weight/volume as a vehicle control (VC) group; 5 mL/kg, the second group with LD of KME (2 g/kg) and the third group with the HD of KME (5 g/kg). All the rats were fasted a day before doing the experiment and allowed access to water only. Then, KME was fed to the animals based on the respective dosage and groups, and then they were monitored for 14 days for any signs of toxicity and mortality. Then, the histological parameters were analyzed after sacrificing the animals. 19 induction of mammary gland tumors in rats Tumor development was induced by injecting the rats with LA7 cells. Briefly, the LA7 cells were plated in a culture flask and allowed to reach 90% of confluence. They were then detached using trypsin. The cells were suspended in normal phosphate-buffered saline (PBS) and centrifuged at 580× g for 5 min, and 2×10 6 cells were counted and suspended in 300 μL of PBS. Then, cells were subcutaneously injected into the left flank mammary fat pad of the rats using a tuberculin syringe and 21 G needle. After incubation with 8-hydroxy-ar-turmerone, the plates were kept at room temperature, and then 50 μL of CaspaseGlo ® Reagent (7 and 9) was added to the wells. The cells were then incubated at room temperature on a plate shaker for 20 min. Luminescent intensity was quantified using a luminescence microplate reader (Infinite M200PRO; Tecan, Männedorf, Switzerland).
cell cycle analysis
After treatment, MCF7 cells were spun down at 580× g for 5 min, the supernatant was discarded and the remaining pellet was washed with PBS. The cell pellets were then fixed with 700 μL of 90% cold ethanol at 4°C overnight. After fixing, the cells were spun down at 200× g for 5 min, the ethanol was discarded and the cells were resuspended in 600 μL of PBS. Approximately 25 μL of RNaseA (10 mg/mL) mixed with 50 μL of propidium iodide (PI; 1 mg/mL) was added to the cells at 37°C for ∼1 h. PI is capable of binding the RNA molecules; therefore, RNase enzymes were added, to allow for direct binding of PI to the DNA, and the fluorescence was measured by the flow cytometer (BD FACSCanto™ II).
22,23 statistical analysis
Counts from different treatment groups were calculated from different observational fields and analyzed for each experiment (n). Each experiment was performed in triplicate and repeated at least three times. The recorded data were fed into a computer program (Window XP, Excel). One-way ANOVA (Dunnett's multiple comparison test) was used for independent samples followed by Tukey's post hoc test using SPSS-17.0 (IBM Corporation, New York, NY, USA) and GraphPad prism (version 4.0; Graphpad Software Inc, La Jolla, CA, USA). A P-value of 0.05 was considered significant, and all the values were reported as mean ± SD.
The mammary tumor development was monitored throughout the experiment. The tumor diameter was measured horizontally and vertically at the end of the experiment. Tumor volume (V) was calculated using the modified ellipsoidal formula: V = (ab2)/2, where "a" and "b" are the longest and shortest diameter of the tumor, respectively. After the experiments, an intraperitoneal injection mixture of xylazine (10 mg/kg body weight) and ketamine HCl (150 mg/kg body weight) was used to anesthetize the animals. 19, 20 histopathology The breast tumors were excised from the rats and fixed in 10% formalin. The fixed tissues were processed in a paraffin tissue-processing machine (Leica Microsystems Inc., Nussloch, Germany), and the paraffin blocks were cut into 5 μm sections and stained with hematoxylin and eosin (H&E) dye and periodic acid-Schiff (PAS) dye (Sigma-Aldrich). The morphology of breast tumor tissue was evaluated by observing the sections under a light microscope (Nikon, Tokyo, Japan).
TUnel assay
Apoptotic cells were captured by combining flourescein-12-dUTP(a) at 3′-OH DNA ends via the terminal recombinant deoxynucleotidyl transferase enzyme (rTdT). The tumor tissue sections were subjected to a DeadEnd™ Fluorometric TUNEL system (Promega Corporation, Madison, WI, USA), according to the manufacturer's instructions, and then captured using a confocal microscope (Zeiss, LSM 70) using standard fluorescein filters. 19 immunohistochemistry Expressions of PCNA, Bax, Bcl-2, p53, p21 and p21 were evaluated using immunohistochemistry analysis. Briefly, after processing the tumor tissues, the sections were incubated with primary antibodies against PCNA, Bcl-2, Bax, p53, p21 and p27 (Santa Cruz Biotechnology). After washing, the sections were incubated with a biotinylated secondary antibody. The sections were evaluated using a DAB Detection Kit (Dako, Glostrup, Denmark). A microscope (BX51; Olympus, Tokoyo, Japan) was used to capture the images of the sections.
annexin V-FiTc assay
Early and late apoptosis induction in MCF7 cells was further examined via the Annexin V-FITC staining assay. Briefly, breast cancer cells (1×10 5 ) were seeded into a chamber , which indicated the presence of an OH group. The 1 H nuclear magnetic resonance (NMR) spectrum showed the existence of two overlapped aromatic signals at δ 7.13 (2H, dd, J =1.3, 7.2 Hz) and δ 7.25 (2H, dd, J =1.3, 7.2 Hz) due to protons on C-3, C-6, C-2 and C-5, respectively ( Figure 1) . A peak at δ 6.08 d (1.1) was assigned to H-10. Another two peaks appeared at δ 3.14 m and 4.29 d (2.9), which was attributed to protons of two methines linked to C-7 and C-8, respectively. Four peaks at δ 1.93 s, 2.3 s, 1.11 d (6.9) and 2.21 were assigned to four methyl groups. The 13 C NMR spectrum of 8-hydroxy-ar-turmerone specified the existence of 15 carbons, counting with five quaternary carbons, six methines and four methyl groups based on the DEPT spectrum (Table 1) .
cytotoxic activity
The MTT assay was performed to determine the level of cell viability and the degree of cytotoxicity produced by the addition of all three extracts to the cells. MCF7 was found to be the most sensitive cells to KME (Figure 2 ). The positive control (tamoxifen; Sigma-Aldrich) was used as the positive control with half maximal inhibitory concentration (IC 50 ) value lower than KME. Dimethyl sulfoxide (DMSO) at a concentration of 0.1% was used as a vehicle control, and the results did not show any sign of toxicity. Moreover, an in vivo study was performed on the KME, whereas the in vitro study was accomplished with 8-hydroxy-ar-turmerone as a bioactive compound (Table 2) .
acute toxicity
The results of the acute toxicity study revealed the nontoxic nature of the plant even at the higher dose tested. During the 14-day monitoring, no signs of mortality were observed and the slides of the kidney and liver confirmed the safety of KME.
size and volume of the tumor
The appearance of the tumor was observed during the early 10 days after the injection of LA7 cells to the rats. Tumor size, percentage and body weights of the animals are presented in Table 3 . No significant decrease in body weight was observed in the control and treatment group animals. However, the tumor size was significantly reduced in the KME-and tamoxifen-treated groups (Figure 3 ).
histopathology
The histopathological observation of the slides from nonneoplastic breast of the rats showed lactiferous ducts and acini with some vessels and stroma. After tumor induction, there was a neoplastic proliferation of epithelial cells with severe pleomorphism and mitotic activity. The treatment Table 1 1 h nMr (500 Mhz) and 13 c nMr (125 Mhz) spectral data of 8-hydroxy-ar-turmerone in cDcl 3 (δ in ppm, J in hz) demonstrated wide areas of necrosis, apoptosis and regression of tumor. In spite of having many changes in the breast tissue, the hepatic and renal tissues had normal histology, including hepatic lobules, renal ducts and glomeruli without any evidence of toxicity or fibrosis (Figure 4 ).
TUnel assay
The TUNEL assay was performed to confirm the induction of apoptosis in the treatment groups. Apoptotic cells are illustrated by the fluorescence green color of the free labeled 3′-OH termini. The result demonstrated that several cells had undergone apoptosis at the high dose (HD) in the KME-and tamoxifen-treated groups, whereas no noticeable numbers of apoptotic cells were witnessed in the low-dose (LD) and control groups ( Figure 5 ).
immunohistochemistry
Immunohistochemistry analysis of the tumor sections revealed that the expression of the tumor markers PCNA and Ki-67 increased in the cancer control group. However, in the treatment groups, these tumor markers were significantly decreased and disappeared ( Figure 6 ). The tumor apoptosis markers Bax, Bcl-2, caspase-3 and p53 were found to exhibit an upregulation trend in the treatment groups, while there was no expression in the cancer control group. Interestingly, Bcl-2 was highly expressed in the cancer control group, where it was decreased in the treatment groups (Figure 7) . The cell cycle markers p21 and p27 were remarkably expressed in the treated groups, while there was negligible expression in the cancer control group (Figure 8 ).
in vitro examination of 8-hydroxy-arturmerone against McF7 cells

Annexin V-fluorescein isothiocyanate (FITC) assay
Induction of early apoptosis was confirmed by phosphatidylserine externalization in 8-hydroxy-ar-turmerone-treated cells. Microscopic observations confirmed the morphological and cellular adjustment under 48 h of treatment as shown in Figure 9 . The MCF7 cells exhibited remarkable blebbing from the cell membrane with positive expression of Annexin V (Figure 9 ). 24 analysis of caspase-9 and caspase-7
Caspase-9 significantly increased after treatment of MCF7 cells with 8-hydroxy-ar-turmerone at 12 h, while caspase-7 remarkably increased at 24 and 48 h after 8-hydroxy-arturmerone treatment (P0.05; Figure 10 
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Discussion
Usage of herbal drugs and medicinal plants for their active compounds has been increasing globally for the management of inflammatory responses and certain cancers. 25 K. odoratissima is one of the culinary plants, which is widely consumed by the people of Iran to keep certain cancers away with its daily use; however, not much effort has been made to study the biologically active compounds of this plant against cancer. 14, 26 KME was investigated for its anticancer potential and possible mechanism against cancer cells. Our study results demonstrated the cytotoxic effect of KME against various cancer cells, including MCF7, LA7, HT29, CEMss, MDA-MB-231, HepG2 and A549. However, MCF7 breast cancer adenoma cells showed the lowest IC 50 with remarkable decrease in the cell population and viability according to the cell cycle arrest; thus, we determined the effects of KME in an animal breast cancer model, and subsequently bioassay-guided assays were performed with 8-hydroxy-ar-turmerone as a bioactive compound in KME. The structure of 8-hydroxy-ar-turmerone was confirmed by 2D NMR spectroscopy, and the presence of carbonyl group at C-9 was demonstrated via a correlation between the carbonyl signal δ 200.2 and the signal due to H-10 at δ 6.08 in the heteronuclear multiple-bond correlation (HMBC) spectrum. The HMBC spectrum also showed correlations between the signals from H-7 to C-6, H-12 to C-11 and H-14 to C-8.
The results of the acute toxicity study show the nontoxic nature of KME, and the microscopic observation illustrates the glomeruli without signs of toxicity or fibrosis with normal hepatic lobules and renal ducts. These outcomes are in line with the usage of this plant by the Iranians for edible purpose; furthermore, oral treatments of HD KME and tamoxifen to the LA7-induced breast cancer groups indicated the suppression of smaller sized tumors compared with the control group. In addition, these results were established by histopathological examination of the tumor sections, which showed the presence of invasive breast tumor in which the ductal morphology of the cancer-induced groups was completely changed and disappeared in most of the breast tissues after KME treatment.
Furthermore, it is well known that PCNA and Ki-67 are the most commonly used proliferative markers for identifying the presence of breast cancer in breast tissues. Interestingly, in the current study, we observed that PCNA and Ki-67 were clearly increased after tumor development as indicated by the immunohistochemistry analysis. Despite the high number of cancer cells in the cancer control group, the number of 
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KMe activates intrinsic pathway of apoptosis in breast cancer cells positive cancer cells was remarkably reduced after KME and tamoxifen treatments.
Moreover, in line with the microscopic and morphological outcomes of our findings supporting the beneficial effects of KME in suppressing the tumor cells, the underlying mechanism can be attributed to apoptosis based on the confirmation of the induction of apoptosis by KME and compound treatments. In the TUNEL assay, the fragmented DNA in apoptotic cells can combine with the flourescein-12-dUTP(a) that produces the green fluorescence dye, which illustrates Drug Design, Development and Therapy 2017:11 submit your manuscript | www.dovepress.com
Dovepress
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KMe activates intrinsic pathway of apoptosis in breast cancer cells the induction of apoptosis in the cells, where HD KME and tamoxifen treatment of the tumor sections confirmed the presence of apoptotic cells. Similarly, the cellular membrane leakage and increase in permeability caused internalization of PS protein, following translocation of the protein from the inner surface to the outer surface of the plasma membrane, and induced Annexin V redistribution from vesicles to the apical pole of the membrane. In turn, all the cells treated with 8-hydroxy-ar-turmerone showed a significant induction of Annexin V response with positive fluorescence expression. As such, our data reveal that 8-hydroxy-ar-turmerone can activate the intrinsic functional membrane in MCF7 cells, thereby causing apoptosis. 27, 28 The commitment of cells to undergo programmed suicide or apoptosis, which is determined by the Bcl-2 family proteins, is crucial for tissue homeostasis, development and immunity. Apoptosis is activated in mammals through an intrinsic pathway, which involves the mitochondria or death receptors in the extrinsic pathway. Mitochondria are regulated in apoptosis through the members of Bcl-2 family proteins. Bcl-2 proteins are either proapoptotic or antiapoptotic and regulate the intrinsic pathway of apoptosis through the mitochondrial membrane.
All intracellularly retained cytochrome c, Bax and Bcl-2 are considered as early mediators of apoptosis; they are, in fact, localized to a great extent in the late apoptotic pathway. 29, 30 A paradigm is that mitochondrial integral membrane protein domains exchange on their way to the cytosol through the mitochondrial membrane potential (MMP), mainly by passing through the mitochondrial membrane transition pores (MPTPs). Our in vitro and in vivo analyses revealed that cancer cells stably express Bax functional protein regardless of the treatments. 22, 31 The upregulation of Bax and the downregulation of Bcl-2 were equally sensitive to both KME and 8-hydroxy-ar-turmerone as well as to tamoxifen. The regulation of the apoptotic modulators was further supported by p53 with KME treatments. The low numbers of cancer cell population bypassing the G 0 /G 1 and G 2 /M phases may directly be delivered by post-apoptotic processing via the conventional cytokines. 32 Caspases have been identified as components of the cellular apoptotic complex. They have also been proposed to have a role in mitochondrial integrity and may serve as initiators for intrinsic/extrinsic succession involved in various cellular processes. 33 Cellular processes, which are essential for nuclear functionality and stability, are maintained by a series of caspases, accompanied with specific enzymatic events. Caspases share some features of both apoptosis and mitosis signaling as well as cytoskeletal protein domains, ie, Bax and Bcl-2. 34 Therefore, studying the functions of caspases as positive regulators of apoptotic cascade is of utmost interest. Our data indicate an appreciable shift of caspase-9 and caspase-7 expressions by 8-hydroxy-ar-turmerone in MCF7 cells. 8-Hydroxy-ar-turmerone clearly acted at the mitochondrial level and increased the expression of caspases in a time-dependent manner, unlike in the untreated cells where the levels of caspase-9 and caspase-7 expressions were unaffected. Caspase-9 activation was initiated at an earlier phase causing an activation of the caspase cascade involved in the intrinsic pathway. The activation of caspase-9 was clearly organized with the help of the apoptosome, where procaspase-9 was converted to caspase-9. This is most likely due to the involvement of the intrinsic pathway. Accordingly, KME-treated sections were analyzed through the expression of the executioner caspase-7, which revealed the activation of caspase-7 in the tumor sections after KME treatment. [35] [36] [37] Drug Design, Development and Therapy 2017:11 submit your manuscript | www.dovepress.com
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KMe activates intrinsic pathway of apoptosis in breast cancer cells Moreover, the in vitro results regarding the expression of p21 and p27 proteins with 8-hydroxy-ar-turmerone treatments were further studied on MCF7 cells to determine the possible characteristics of arrest. Our findings are in line with the cyclin-dependent kinase inhibitors that regulate the proliferation of cells in association with other proteins. The upregulation of these proteins can stop the proliferation of the cells as indicated by our results, which show the upregulation of p21 and p27 after treatment with 8-hydroxy-arturmerone and KME in vitro and in vivo, respectively, while there was no significant expression in the cancer control group.
Conclusion
Overall, our study results revealed that K. odoratissima has potential anticancer effects against breast cancer cells in vitro and in vivo. Our data proposed that KME can initiate antiproliferative and apoptotic effects and destroy the tumor cells by disrupting the cell membrane and dysfunctioning the mitochondrial metabolic cascade, as well as disrupting the expression of Bax and Bcl-2 via the intrinsic pathway. 8-Hydroxy-ar-turmerone is identified as the active compound that contributes best to the anticancer activity.
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